Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...
The officials said that a proposal to this effect was sent to the state police department, and it was approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback